Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yair Alster

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cornea|March 27, 2003
Colchicine in tear fluid of treated patients with familial Mediterranean feverIgal Leibovitch, Yair Alster, Jean Michel Scherrmann, et al.
The Ocular Surface|November 29, 2024
Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction over six months of treatment: A Phase 2, vehicle-controlled, randomized extension trialLaura E Downie, Jennifer P Craig, Fiona Stapleton, et al.
The Ocular Surface|July 21, 2023
Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trialStephanie L Watson, Lyndon W Jones, Fiona Stapleton, et al.
Retina (Philadelphia, Pa.)|April 5, 2005
Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degenerationMichaela Goldstein, Anat Loewenstein, Adiel Barak, et al.
Ophthalmology|September 13, 2005
Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization studyYair Alster, Neil M Bressler, Susan B Bressler, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cornea|March 27, 2003
Colchicine in tear fluid of treated patients with familial Mediterranean feverIgal Leibovitch, Yair Alster, Jean Michel Scherrmann, et al.
The Ocular Surface|November 29, 2024
Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction over six months of treatment: A Phase 2, vehicle-controlled, randomized extension trialLaura E Downie, Jennifer P Craig, Fiona Stapleton, et al.
The Ocular Surface|July 21, 2023
Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trialStephanie L Watson, Lyndon W Jones, Fiona Stapleton, et al.
Retina (Philadelphia, Pa.)|April 5, 2005
Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degenerationMichaela Goldstein, Anat Loewenstein, Adiel Barak, et al.
Ophthalmology|September 13, 2005
Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization studyYair Alster, Neil M Bressler, Susan B Bressler, et al.
Pageof 2